Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Development of MASLD Among Survivors of Breast or Colorectal Cancer

NCT07280143 is registered in ClinicalTrials.gov with University of Bern as lead sponsor.

NCT NCT07280143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07280143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Development of MASLD Among Survivors of Breast or Colorectal Cancer
Lead sponsor
University of Bern
Phase
Observational
Overall status
Recruiting
Start date
November 14, 2025
Completion date
November 30, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer survivors, colorectal (colon or rectal) cancer survivors, masld/mash (metabolic dysfunction-associated steatotic liver disease / metabolic dysfunction-associated steatohepatitis)